Article
Next-generation sequencing in drug development: target identification and genetically stratified clinical trials.
Drug discovery today - 1 Oct 2018
Doostparast Torshizi Abolfazl, Wang Kai
Abstract excerpt
Next-generation sequencing (NGS) enabled high-throughput analysis of genotype-phenotype relationships on human populations, ushering in a new era of genetics-informed drug development. The year 2017 was remarkable, with the first FDA-approved gene therapy for cancer (Kymriah™) and for inherited diseases (LUXTURNA™), the first multiplex NGS panel for companion diagnostics (MSK-IMPACT™) and the first drug targeting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
